The invention, relates to the field of medical biology, program ligand to death (PDL1), single domain antibodies conjugated protein is disclosed. In particular, the present invention, program ligand binding molecule (PDL1) 1 top and its use, particularly PDL1-associated disease, for example to prevent or treat and/or diagnosis using tumor is disclosed.